slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
23,65 TWD | +0,85% |
|
+3,05% | +5,82% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biotechnology Testing
76,1
%
| 242 | 75,2 % | 214 | 76,1 % | -11,73% |
Instrument
23,9
%
| 80 | 24,8 % | 67 | 23,9 % | -16,24% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
100,0
%
| 322 | 100,0 % | 281 | 100,0 % | -12,85% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Fu Chien Chen
CEO | Chief Executive Officer | - | 21-01-03 |
Ying Jen Chen
DFI | Director of Finance/CFO | - | - |
I Hsing Lin
BRD | Director/Board Member | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sheng-In Cheng
BRD | Director/Board Member | - | 12-12-17 |
Jui Hsun Chen
BRD | Director/Board Member | - | 12-12-17 |
Fu Chien Chen
CEO | Chief Executive Officer | - | 21-01-03 |
Ying Jen Chen
DFI | Director of Finance/CFO | - | - |
Jui Chen Lin
BRD | Director/Board Member | - | - |
I Hsing Lin
BRD | Director/Board Member | - | - |
Hsiao Min Li
BRD | Director/Board Member | - | 12-12-17 |
Wei Wei Peng
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 23 304 000 | 7 473 248 ( 32,07 %) | 0 | 32,07 % |
Bedrijfsgegevens
![Adres Welgene Biotech Co.,Ltd.(6661)](https://cdn.zonebourse.com/static/address/45428657.png)
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,82% | 17,01 mln. | |
+34,14% | 51,12 mld. | |
-6,54% | 39,4 mld. | |
+34,92% | 38,48 mld. | |
+12,62% | 26,36 mld. | |
-12,11% | 26,22 mld. | |
-13,43% | 20,96 mld. | |
+43,73% | 14,02 mld. | |
+31,81% | 12,49 mld. | |
-4,54% | 11,61 mld. |
- Beurs
- Aandelen
- Koers 6661
- Onderneming Welgene Biotech Co.,Ltd.